source
- GC Therapeutics appoints former BlueRock executive Stefan Irion as chief scientific officerGC Therapeutics announced that Stefan Irion has joined the company as its new chief scientific officer. Irion previously served in the same capacity at BlueRock Therapeutics. Irion brings experien…
- GSK reports strong Phase 3 results for Ionis-licensed chronic hepatitis B therapyGSK disclosed data from two late‑stage trials of a chronic hepatitis B treatment it licensed from Ionis Pharmaceuticals. The studies evaluated the drug’s efficacy and safety in patients with chroni…